Sunday, February 22, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Analyst Downgrade Casts Shadow Over Coinbase Outlook

Rodolfo Hanigan by Rodolfo Hanigan
February 22, 2026
in Analysis, Blockchain, Crypto Stocks
0
Coinbase Stock
0
SHARES
2
VIEWS
Share on FacebookShare on Twitter

A prominent Wall Street research firm has adopted a decidedly bearish stance on Coinbase Global, Inc., slashing its price target and reiterating a sell recommendation. Compass Point Research & Trading significantly reduced its target for the cryptocurrency exchange’s shares to $140, down from a previous estimate of $190.

Trading Volumes and Competitive Pressures Drive Pessimism

The downgrade follows the company’s latest quarterly earnings report, which revealed a net loss of $667 million. Analysts at Compass Point point to a marked decline in user trading activity across both spot and derivative markets since those results were published. They argue that current market expectations for Coinbase’s performance this year appear overly optimistic.

The firm’s analysis highlights a concerning historical pattern: during past “crypto winters,” retail investor participation has typically retreated. There is a growing concern that trading volumes could approach historically low levels. Compass Point strategists also note an intensified competitive landscape, a shift from previous market cycles. Established fintech companies and electronic brokers are making deeper inroads, presenting Coinbase with more direct rivalry than it has faced before.

Should investors sell immediately? Or is it worth buying Coinbase?

In their view, these structural challenges and market headwinds outweigh any potential for short-term recovery, justifying the maintained sell rating.

Diverging Views in the Analyst Community

While Compass Point’s skepticism is shared by some peers, the overall analyst picture for Coinbase remains mixed. Following the quarterly report, other firms including Piper Sandler and Needham also adjusted their price targets downward.

However, a consensus compiled by MarketBeat suggests a more moderate outlook. The aggregate rating currently stands at “Moderate Buy.” This rating is supported by recommendations from 19 analysts advocating a buy position, contrasted with 12 advising holders to maintain their positions and two recommending selling. The spectrum of opinion reflects varying interpretations of the impact of weak trading volumes, ranging from cautious optimism to pronounced doubt about the company’s near-term trajectory.

Ad

Coinbase Stock: Buy or Sell?! New Coinbase Analysis from February 22 delivers the answer:

The latest Coinbase figures speak for themselves: Urgent action needed for Coinbase investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 22.

Coinbase: Buy or sell? Read more here...

Tags: Coinbase
Rodolfo Hanigan

Rodolfo Hanigan

Related Posts

Eli Lilly Stock
Analysis

Eli Lilly’s Dual Catalysts: Immunology Data and Analyst Confidence

February 22, 2026
Oxford Lane Capital Stock
Analysis

Oxford Lane Capital: A Strategic Pivot Amidst Valuation Concerns

February 22, 2026
Commerce Bancshares Stock
Analysis

Navigating Dividends and Discipline: The Commerce Bancshares Outlook

February 22, 2026
Next Post
Gemini Space Station Stock

Leadership Exodus and Deepening Losses Plague Gemini Space Station

NASDAQ 100 Stock

Tech Stocks Rebound as Tariff Ruling Eclipses Growth Concerns

Revolve LLC Stock

Revolve Group Faces Critical Earnings Test

Recommended

Leonardo Stock

Defense Giant Leonardo Defies Market Slump with Standout Performance

6 months ago
Nel ASA Stock

Nel ASA Shares Show Signs of Life

3 months ago
Finance_ Charts for stock trading

Truist Securities Analyst Maintains Hold Rating on Main Street Capital with Increased Price Target

2 years ago
Finance_Capitalization

Analyst Reaffirms Positive Outlook on Cohen Steers with Increased Price Target

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Nio’s Battery Swap Success in China Contrasts with European Market Challenges

Oxford Lane Capital: A Strategic Pivot Amidst Valuation Concerns

Navigating Dividends and Discipline: The Commerce Bancshares Outlook

Block’s Strategic Expansion: Square Ecosystem Grows Through Integration

Liberty Media Set to Unveil Q4 2025 Performance

Sangamo Therapeutics Seeks Regulatory Approval for Fabry Disease Gene Therapy

Trending

FlexShares STOXX US ESG Select Index Fund Stock
ETF

A Closer Look at the FlexShares US ESG ETF’s Portfolio and Costs

by Kennethcix
February 22, 2026
0

For investors seeking exposure to US companies with strong sustainability credentials, the FlexShares STOXX US ESG Select...

Eli Lilly Stock

Eli Lilly’s Dual Catalysts: Immunology Data and Analyst Confidence

February 22, 2026
XTI Aerospace Stock

XTI Aerospace Secures Strategic Funding from JPMorgan for Drone Expansion

February 22, 2026
Nio Stock

Nio’s Battery Swap Success in China Contrasts with European Market Challenges

February 22, 2026
Oxford Lane Capital Stock

Oxford Lane Capital: A Strategic Pivot Amidst Valuation Concerns

February 22, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • A Closer Look at the FlexShares US ESG ETF’s Portfolio and Costs
  • Eli Lilly’s Dual Catalysts: Immunology Data and Analyst Confidence
  • XTI Aerospace Secures Strategic Funding from JPMorgan for Drone Expansion

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com